Feasibility and Adherence of a Multicomponent Digital Health Monitoring Platform in Ambulatory Heart Failure: Multicenter Observational Study
Background Digital health platforms combining wearable biosensors with smartphone apps offer scalable approaches to heart failure (HF) management, yet sustained patient engagement and initial technology adoption, particularly among older adults, remain uncertain. Objective We conducted a prospective, multicenter observational study to explore the feasibility and adherence of using a digital health monitoring platform for 8 weeks in a population of ambulatory patients with HF. Methods In this prospective multicenter observational study, patients with New York Heart Association (NYHA) class I to III HF were prescreened across 6 institutions in the United States and Singapore. Participants wore an Everion multisensor armband and an Apple Watch continuously and completed daily electrocardiograms (ECGs), daily symptom questionnaires, weekly voice recordings, and biweekly KCCQ-12 (Kansas City Cardiomyopathy Questionnaire-12) assessments. Prespecified end points included recruitment yield, device wear-time, task-specific compliance, dropout rate, and adverse events. Results Of 3386 prescreened individuals, 520 (15.4%) were clinically eligible; 66 consented (1.9% of prescreened; 12.7% of eligible), with technology-related concerns driving most declinations. Among 65 enrolled patients (mean age 56.5, SD 12.3 years; n=53, 81.5% male), 52 (80%) completed 8 weeks. Mean daily wear-time was 11.7 (SD 5.7) hours, significantly exceeding the 8-hour benchmark (P<.001). Task completion rates were 76.6% (2788/3640, daily ECG), 68.5% (2493/3640, daily symptoms), 86.5% (450/520, weekly voice), and 88.1% (229/260, biweekly KCCQ-12). Adherence did not differ significantly by age group (P=.81). No serious device-related adverse events occurred. Conclusions Enrolled patients with HF, including older adults, sustained robust engagement with a multicomponent digital platform over 8 weeks. However, technology-related concerns prevented most eligible patients from enrolling, identifying adoption, not adherence, as the primary barrier to scalable remote monitoring. Trial Registration ClinicalTrials.gov NCT04191356; https://clinicaltrials.gov/study/NCT04191356
Authors
- Joseph S. Ross (ORCID: https://orcid.org/0000-0002-9218-3320)
- Stephanie J. Zawada (ORCID: https://orcid.org/0000-0002-2022-4189)
- Charles J. Bruce (ORCID: https://orcid.org/0000-0002-7481-5793)
- Christopher John McLeod (ORCID: https://orcid.org/0000-0001-6851-0152)
- Felis Dwiyasa
- Kuldeepsingh Rajput (ORCID: https://orcid.org/0000-0001-5655-7623)
- Maulik D. Majmudar (ORCID: https://orcid.org/0000-0002-8894-7981)
- Yan He (ORCID: https://orcid.org/0000-0002-6496-8016)
- Hao Chen (ORCID: https://orcid.org/0000-0003-2322-494X)
- Sy Jackie Lou Velarde
Publication Details
- Journal
- JMIR Formative Research
- Published
- 2026-11-19
- DOI
- https://doi.org/10.2196/99974
- Primary Topic
- Mobile Health and mHealth Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00